lngfrmlogo

CRISPR technology

Bank of America Boosts Stake in CRISPR Therapeutics Amid Mixed Financial Signals

Bank of America increases its stake in CRISPR Therapeutics, signaling confidence amid financial challenges. Despite a recent quarterly loss, the biotech firm continues to show revenue growth and attracts further institutional investments.

By
LNGFRM Team
  • 05/15/2025
  • - BiotechnologyCompany NewsNews
"Graphic illustration featuring a DNA double helix in the center, surrounded by stylized blue mountains, clouds, and a silhouette of buildings at the bottom."
  • Biotechnology
Bank of America Boosts Stake in CRISPR Therapeutics Amid Mixed Financial Signals
LNGFRM Team
© 2026 LNGFRM. All rights reserved.